The rise of Viagra initially sparked a boom for pharma, but recent changes present a uncertain outlook for those considering a stake. Off-patent versions are eating into earnings, and ongoing patent challenges add https://asiyauybl779514.shotblogs.com/sildenafil-and-big-pharma-a-precarious-play-55291951